MATERNAL MORBIDITY AMONG PATIENTS WITH SEVERE OR LIFE-LIMITING FETAL CONDITIONS

IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
S Yazdani, ME Weiss, AS McLennan, MD Creinin
{"title":"MATERNAL MORBIDITY AMONG PATIENTS WITH SEVERE OR LIFE-LIMITING FETAL CONDITIONS","authors":"S Yazdani,&nbsp;ME Weiss,&nbsp;AS McLennan,&nbsp;MD Creinin","doi":"10.1016/j.contraception.2024.110579","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To compare maternal morbidity with pregnancy continuation or abortion in pregnancies with severe or life-limiting fetal conditions.</div></div><div><h3>Methods</h3><div>We extracted data from a de-identified quality database of patients with fetal conditions who received care at our institution to compare maternal outcomes with pregnancy continuation and abortion. We included patients with fetal conditions which would significantly impact future quality of life, require serious intervention to sustain life, or be incompatible with life after delivery. We excluded multiple gestations, previable membrane rupture or fetal demise at time of diagnosis, concern for placenta accreta, and patients that delivered outside of our institution. We considered major morbidity as unplanned intra-abdominal surgery, intensive care unit admission, blood transfusion, venous thromboembolism, readmission within 6 weeks, sepsis, fourth-degree vaginal laceration, uterine rupture, and eclampsia. Minor morbidity included uterine infection requiring intravenous antibiotics, retained products requiring repeat procedure, shoulder dystocia, blood patch post-epidural, cervical lacerations, and third-degree vaginal lacerations.</div></div><div><h3>Results</h3><div>Overall, 387 and 423 individuals chose pregnancy continuation and abortion, respectively. Major morbidity occurred in 23(5.9%) and 7(1.7%), respectively (OR 3.76, 95% CI 1.59-8.85). Minor morbidity occurred in 32(8.3%) and 31(7.3%), respectively (OR 1.20, 95% CI 0.72-2.00). In the continuation group, documented fetal/neonatal demise occurred in 46(11.9%) and cesarean delivery occurred in 180(46.5%) patients. Major abdominal surgery (excluding cesarean delivery) occurred in 2(0.5%) and 2(0.5%), respectively. No mortality occurred in either group.</div></div><div><h3>Conclusions</h3><div>We observed increased maternal morbidity with pregnancy continuation compared to abortion in pregnancies with severe or life-limiting fetal conditions.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0010782424002749","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To compare maternal morbidity with pregnancy continuation or abortion in pregnancies with severe or life-limiting fetal conditions.

Methods

We extracted data from a de-identified quality database of patients with fetal conditions who received care at our institution to compare maternal outcomes with pregnancy continuation and abortion. We included patients with fetal conditions which would significantly impact future quality of life, require serious intervention to sustain life, or be incompatible with life after delivery. We excluded multiple gestations, previable membrane rupture or fetal demise at time of diagnosis, concern for placenta accreta, and patients that delivered outside of our institution. We considered major morbidity as unplanned intra-abdominal surgery, intensive care unit admission, blood transfusion, venous thromboembolism, readmission within 6 weeks, sepsis, fourth-degree vaginal laceration, uterine rupture, and eclampsia. Minor morbidity included uterine infection requiring intravenous antibiotics, retained products requiring repeat procedure, shoulder dystocia, blood patch post-epidural, cervical lacerations, and third-degree vaginal lacerations.

Results

Overall, 387 and 423 individuals chose pregnancy continuation and abortion, respectively. Major morbidity occurred in 23(5.9%) and 7(1.7%), respectively (OR 3.76, 95% CI 1.59-8.85). Minor morbidity occurred in 32(8.3%) and 31(7.3%), respectively (OR 1.20, 95% CI 0.72-2.00). In the continuation group, documented fetal/neonatal demise occurred in 46(11.9%) and cesarean delivery occurred in 180(46.5%) patients. Major abdominal surgery (excluding cesarean delivery) occurred in 2(0.5%) and 2(0.5%), respectively. No mortality occurred in either group.

Conclusions

We observed increased maternal morbidity with pregnancy continuation compared to abortion in pregnancies with severe or life-limiting fetal conditions.
严重或危及生命的胎儿疾病患者的孕产妇发病率
方法我们从一个去标识化的质量数据库中提取了在我院接受治疗的胎儿疾病患者的数据,以比较继续妊娠和人工流产对产妇的影响。我们纳入了胎儿状况会严重影响未来生活质量、需要严重干预才能维持生命或产后无法存活的患者。我们排除了多胎妊娠、胎膜早破或诊断时胎儿夭折、胎盘早剥以及在本院外分娩的患者。我们认为主要发病情况包括计划外腹腔内手术、入住重症监护室、输血、静脉血栓栓塞、6 周内再次入院、败血症、阴道四度裂伤、子宫破裂和子痫。轻微发病包括需要静脉注射抗生素的子宫感染、需要重复手术的残留物、肩难产、硬膜外麻醉后血贴、宫颈裂伤和阴道三度裂伤。主要发病率分别为 23 例(5.9%)和 7 例(1.7%)(OR 3.76,95% CI 1.59-8.85)。轻微发病率分别为 32 例(8.3%)和 31 例(7.3%)(OR 1.20,95% CI 0.72-2.00)。在继续分娩组中,有记录的胎儿/新生儿死亡有 46 例(11.9%),剖宫产有 180 例(46.5%)。分别有 2 例(0.5%)和 2 例(0.5%)患者接受了大型腹部手术(不包括剖宫产)。结论我们观察到,与人工流产相比,在胎儿病情严重或生命垂危的孕妇中,继续妊娠会增加产妇的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Contraception
Contraception 医学-妇产科学
CiteScore
4.70
自引率
17.20%
发文量
211
审稿时长
69 days
期刊介绍: Contraception has an open access mirror journal Contraception: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信